MOH
Molina Healthcare Inc
Molina Healthcare Inc historical holders
total: 6
Scion Asset Management Molina Healthcare Inc transactions over time
- Total transactions:
- 5
- New positions:
- 2
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 1
- Held since:
- 2025 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2025 Q3
Michael Burry has been an institutional investor in Molina Healthcare Inc (MOH) since 2024 Q2. According to 2025 Q3 report, Michael Burry holds 125,000 shares with a market value of roughly $23.92M representing 35.11% of their equity portfolio. The fund/company first acquired MOH in 2024 Q2, initially purchasing 24,530 shares. Michael Burry later completely sold out the position and reinvested in MOH again in 2025 Q3. Since the initial investment, Scion Asset Management has made 4 more transactions in this position.
Does Michael Burry still hold MOH?
Yes, Michael Burry continues to hold Molina Healthcare Inc (MOH). According to their 2025 Q3 report, they maintain a position of 125,000 shares valued at approximately $23.92M, representing 35.11% of their equity portfolio.
When did Michael Burry first invest in MOH?
Michael Burry first invested in Molina Healthcare Inc (MOH) in 2024 Q2 at the reported quarter-end price of $297.30 per share, acquiring 24,530 shares in their initial purchase.
What is Michael Burry's average cost basis for MOH?
Based on historical transaction data, Michael Burry's estimated cost basis for Molina Healthcare Inc (MOH) is approximately $191.36 per share. This represents their average reported price* across all buy transactions.
Has Michael Burry reinvested in MOH after selling?
Yes, Michael Burry has shown renewed interest in Molina Healthcare Inc (MOH). After completely selling their position, they reinitiated an investment in 2025 Q3, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $191.36
MOH transactions history by Scion Asset Management
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
35.11%
|
125,000
|
$191.36
|
$23,920,000
|
new
|
+35.11%
|
|
2025 Q1
|
0.00%
|
0
|
$291.05
|
|
-100% (-25,000)
|
-9.4%
|
|
2024 Q4
|
9.40%
|
25,000
|
$291.05
|
$7,276,250
|
-16.67% (-5,000)
|
-1.75%
|
|
2024 Q3
|
12.45%
|
30,000
|
$344.56
|
$10,336,800
|
+22.30% (+5,470)
|
+2.27%
|
|
2024 Q2
|
13.89%
|
24,530
|
$297.30
|
$7,292,769
|
new
|
+13.89%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.